Article
APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
Nature communications - 2 Nov 2020
Zhao Jing, Fu Yuan, Yamazaki Yu, Ren Yingxue, Davis Mary D, Liu Chia-Chen, Lu Wenyan, Wang Xue, Chen Kai, Cherukuri Yesesri, Jia Lin, Martens Yuka A, Job Lucy, Shue Francis, Nguyen Thanh Thanh, Younkin Steven G, Graff-Radford Neill R, Wszolek Zbigniew K, Brafman David A, Asmann Yan W, Ertekin-Taner Nilüfer, Kanekiyo Takahisa, Bu Guojun
Abstract excerpt
APOE4 is the strongest genetic risk factor associated with late-onset Alzheimer's disease (AD). To address the underlying mechanism, we develop cerebral organoid models using induced pluripotent stem cells (iPSCs) with APOE ε3/ε3 or ε4/ε4 genotype from individuals with either normal cognition or AD dementia. Cerebral organoids from AD patients carrying APOE ε4/ε4 show greater apoptosis and decreased synaptic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.